Results 51 to 60 of about 4,233 (228)
Blocking or enhancing effects of some basic emollients in UVA penetration [PDF]
Anais Brasileiros de Dermatologia, 2018 : Background: Topical agents used in combination with phototherapy or photochemotherapy may have both blocking or enhancing effects in ultraviolet rays.
Sevgi Akarsu +3 more
doaj +1 more source
Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review
JEADV Clinical Practice, Volume 5, Issue 2, Page 651-655, June 2026.ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos +2 more
wiley +1 more source
Generalized syringotropic mycosis fungoides responsive to total skin electron beam therapy
Dermatologica Sinica, 2014 A case of syringotropic mycosis fungoides without internal organ involvement received total skin electron beam therapy (TSEBT) and evolved into poikilodermatous mycosis fungoides.
Pei-Hsuan Lu +4 more
doaj +1 more source
PD02: Oral psoralen + ultraviolet A therapy (
, 2022 openalex +1 more source
Antinuclear antibodies during Puva therapy
Acta Dermato-Venereologica, 1979 During PUVA therapy 7 patients out of 34 with severe psoriasis developed circulating antinuclear antibodies (ANA) (21%). Before treatment only 3 patients of 50 (6%) considered for PUVA had detectable ANA. The ANA titres were usually low. Antibodies against native DNA as studied with the Crithidia luciliae test, were not found, and blood and urinary ...
M, Bjellerup +4 more
openaire +2 more sources
JEADV Clinical Practice, Volume 5, Issue 2, Page 529-537, June 2026.ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won +11 more
wiley +1 more source
Anais Brasileiros de Dermatologia, 2008 Na patogênese do vitiligo tem-se enfatizado o papel das células T citotóxicas. Identificadas pelo antígeno linfocitário cutâneo (CLA), essas células já foram descritas no sangue de pacientes com outras dermatoses e podem ser depletadas pela fototerapia ...
Daniela Pereira Antelo +2 more
doaj +1 more source
Photochemotherapy (PUVA): An Overview
Journal of Indian Academy of Oral Medicine and Radiology, 2010 Photochemotherapy (PUVA) has become a useful alternative in dermatologic therapy. Start from historical date up to modern era the safe and useful modes of PUVA has been documented in many immunological disorder.
Fakir Mohan Debta +3 more
doaj
scRNA‐Seq reveals anti‐lymphoma immune responses in mogamulizumab‐associated skin eruptions
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1078-1090, June 2026.CCR4 was expressed in malignant clones and regulatory T cells in untreated CTCL, that were decreased in MAR. Malignant clones in MAR showed a silenced phenotype with decreases in central memory markers SELL and CCR7, and GTP‐binding member GIMAP7 and upregulation of MMP2 inhibitor TIMP2 and tumour suppressor gene RUNX3.
Shannon Meledathu +13 more
wiley +1 more source
PUVA-bath photochemotherapy in the treatment of psoriasis [PDF]
Саратовский научно-медицинский журнал, 2012 <p><em>Aims. </em>The study aimed to evaluate the effcacy of PUVA-bath photochemotherapy in the treatment of the severe psoriasis. <em>Materials and methods. </em>Twenty six patients aged from 18 to 56 were examined.
Slesarenko N.A. +2 more
doaj